Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-23-023680

Options or other derivatives

  • Chief Operating Officer acquired 206,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-04 Grant or award : show line 1 in the form Stock Option (right to buy) +206,000 206,000 D
Loading xslF345X04/doc4.xml…